Medicaid officials in 3 states have received a green light from the federal government to form a drug-buying collaborative designed to negotiate lower prices from pharmaceutical manufacturers. The new Sovereign States Drug Consortium combines the drug-buying power of Maine, Vermont, and Iowa in an effort to pressure 58 different drug makers to lower their prices on >1300 medications used by Medicaid patients. The system has been in use in Maine for nearly a year, and officials there said that its Medicaid program has already saved >$1 million.
A key element of the plan involves limiting the role of pharmacy benefit managers to ensure that all the negotiated savings are passed on to the states. A group of 7 other states has formed a similar buying group called the National Medicaid Pooling Initiative, and officials of additional state Medicaid programs have expressed interest in forming similar consortia.
In Seniors: Consider CMV Serostatus
When Recommending Flu Vaccine
Older people who have cytomegalovirus seem to have less robust responses to the trivalent influenza vaccine than those who do not have CMV.
News from the year's biggest meetings
Clinical features with downloadable PDFs